UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 103 filers reported holding UROGEN PHARMA LTD in Q3 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $736,576 | +173.4% | 52,575 | +101.9% | 0.00% | – |
| Q2 2023 | $269,452 | -87.6% | 26,034 | -88.9% | 0.00% | – |
| Q1 2023 | $2,170,781 | +198.9% | 234,933 | +187.0% | 0.00% | – |
| Q4 2022 | $726,205 | +305.7% | 81,872 | +280.8% | 0.00% | – |
| Q3 2022 | $179,000 | -37.0% | 21,500 | +47.5% | 0.00% | – |
| Q1 2021 | $284,000 | -72.4% | 14,580 | -74.5% | 0.00% | – |
| Q4 2020 | $1,028,000 | -44.4% | 57,092 | -40.4% | 0.00% | – |
| Q3 2020 | $1,848,000 | -69.8% | 95,796 | -59.1% | 0.00% | -100.0% |
| Q2 2020 | $6,113,000 | +8.4% | 234,007 | -26.0% | 0.00% | -33.3% |
| Q1 2020 | $5,641,000 | -47.5% | 316,210 | -1.8% | 0.00% | 0.0% |
| Q4 2019 | $10,743,000 | +152.7% | 321,945 | +80.4% | 0.00% | +200.0% |
| Q3 2019 | $4,252,000 | -35.0% | 178,429 | -2.0% | 0.00% | 0.0% |
| Q2 2019 | $6,542,000 | +257.7% | 182,060 | +267.8% | 0.00% | 0.0% |
| Q1 2019 | $1,829,000 | +431.7% | 49,500 | +518.8% | 0.00% | – |
| Q4 2018 | $344,000 | -42.4% | 8,000 | -36.7% | 0.00% | – |
| Q3 2018 | $597,000 | – | 12,641 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,620,545 | $36,713,835 | 6.69% |
| Wildcat Capital Management, LLC | 495,606 | $6,943,440 | 2.79% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 508,883 | $7,129,451 | 2.16% |
| Opaleye Management Inc. | 320,000 | $4,483,200 | 1.46% |
| AlphaCentric Advisors LLC | 165,000 | $2,311,650 | 1.31% |
| Soleus Capital Management, L.P. | 372,000 | $5,211,720 | 0.48% |
| EAM Investors, LLC | 170,523 | $2,389,027 | 0.46% |
| RA Capital Management | 1,483,697 | $20,786,595 | 0.41% |
| Parkman Healthcare Partners LLC | 145,311 | $2,035,807 | 0.37% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,303,031 | $32,265,464 | 0.29% |